The neurobiology of depression

In recent decades, pharmacotherapy for depression has undergone dramatic changes. In contrast to the formerly relatively small number of available preparations, the entire range of antidepressants is now practically available to clinicians. Many of them have been launched only in recent years, with the market demand for these preparations constantly increasing, further initiating research in this area. On the eve of the epidemic of depression, the issues of nosology, etiology, prevention, and treatment of this disorder become a priority for anyone who tries to help their loved ones. Pharmacological therapy of depression requires physicians to make the right choice according to world guidelines, close monitoring of the patient, and to control side effects and interactions. Due to the overload of psychiatrists and the high prevalence of depression, patients suffering from depression are often marginalized, stigmatized and inadequately cared for. Therefore, a Master of Pharmacy, through an interdisciplinary approach and practice in pharmaceutical care, can contribute to a rational approach to patient treatment through: monitoring patient compliance, counseling on side effects and drug interactions, and finally supporting a patient with depression to help improve quality of life.